Microbicidal paint was used in the oncology unit of Northside Hospital Healthcare System facility in Cummings, ga., according to a case study on from Sherwin-Williams Paint Shield.
The microbicidal properties of the paint were attractive given the compromised immune system of the patient population.
Paint Shield is the first EPA-registered microbicidal paint and kills greater than 99.9 percent of Staph (Staphylococcus aureus), MRSA (Methicillin-resistant Staphylococcus aureus), E. coli (Escherichia coli), VRE (Vancomycinresistant Enterococcus faecalis) and Enterobacter aerogenes within two hours of exposure on the painted surface, according to the case study.
Charging Ahead: Incentives Driving EV Charging in Healthcare Facilities
Outpatient Growth and the Future of Healthcare Real Estate
Mount Sinai South Nassau Opens Expanded Emergency Department
Lehigh Valley Health Network to Open Fourth Neighborhood Hospital in 2026
Creating an Emergency Preparedness Plan with NFPA 99